527.05USD+0.45%Mkt Cap: 195.86B $P/E: 28.941d ago
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationall…
Industry Peers
Diagnostics & Research$140.88BUSDP/E 38.7
$46.71BUSDP/E 45.1
$44.46BUSDP/E 41.5
$38.66BUSD
$37.93BUSDP/E 27.0
$36.96BUSDP/E 48.0
$34.69BUSDP/E 25.8
$28.78BUSDP/E 34.6
$26.19BUSDP/E 30.4
$22.96BUSDP/E 22.9
$22.70BUSDP/E 24.5
$21.22BUSD
$15.37BUSDP/E 33.9
$12.97BUSDP/E 27.0
$12.53BUSDP/E 54.0
$11.24BUSD
$9.01BUSDP/E 21.0
$5.83BUSDP/E 234.8
$5.64BUSD
$5.25BUSDP/E 44.9
$5.16BUSD
$4.55BUSDP/E 52.8
$3.70BUSDP/E 26.1
$3.37BUSD
$3.09BUSD
$1.95BUSD
$1.84BUSD
$1.54BUSDP/E 39.0
$1.55BUSDP/E 23.5
$1.47BUSD
$1.47BUSD
$1.01BUSDP/E 21.1
$1.02BUSD
$719.43MUSD
$655.97MUSDP/E 42.7
$583.63MUSD
$550.63MUSD
$297.91MUSDP/E 3.0
$288.48MUSD
$221.82MUSD
$164.03MUSD
$140.36MUSD
$107.51MUSD
$97.25MUSD
$89.37MUSDP/E 17.2
$76.80MUSD
$61.29MUSD
$42.54MUSD
$29.48MUSD
$26.61MUSD
$22.25MUSD
$17.72MUSD
$12.71MUSD
$9.88MUSD
$8.70MUSD
$7.73MUSD
$8.04MUSD
$7.13MUSD
$6.48MUSD
$6.44MUSD
$4.66MUSD
$4.82MUSD
$3.86MUSDP/E 2.8
$3.59MUSD
$3.29MUSD
$2.79MUSD
$2.17MUSD
$1.07MUSD
$314.2KUSDP/E Infinity
$5.6KUSD
Indicators:|
Key Statistics
Company
Market Cap195.86B $
Enterprise Value235.03B $
Revenue (TTM)45.20B $
Gross Profit18.24B $
Net Income (TTM)6.70B $
Revenue/Share120.36 USD
Last Price527.05 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees125.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS8835561023
Valuation
P/E (Trailing)28.94
P/E (Forward)19.25
PEG1.68
EV/EBITDA20.81
EV/Revenue5.20
P/S4.31
P/B3.75
EPS (TTM)18.73
EPS (Forward)27.26
52W Range
403.3651% of range643.99
52W High643.99 USD
52W Low403.36 USD
Profitability
Gross Margin40.93%
Oper. Margin17.89%
EBITDA Margin24.99%
Profit Margin15.05%
ROE12.55%
ROA6.08%
Growth
Revenue Growth6.20%
Earnings Growth11.30%
Cash Flow & Leverage
Operating CF7.82B $
CapEx (TTM)1.52B $
FCF Margin12.21%
FCF Yield2.82%
Net Debt39.91B $
Net Debt/EBITDA3.53
Balance Sheet
Debt/Equity0.74
Current Ratio1.53
Quick Ratio0.97
Book Value/Sh139.75 USD
Cash/Share8.762 USD
Dividends
Fwd Div Rate1.880 USD
Trail. Div Rate1.760 USD
Div. Yield0.37%
5Y Avg Yield0.26%
Payout Ratio9.68%
Ex-Div DateJun 15, 2026
Pay DateJul 15, 2026
Splits
Last Split3:2
Split DateJun 6, 1996
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)590.77 USD
Upside (mean)+12.1%
Target Range490.00 USD – 750.00 USD
$490.00+12.1% to mean$750.00
# Analysts26
Ownership
Shares Out.371.62M
Float370.67M
Insiders0.15%
Institutions94.02%
Short Interest
Short Ratio1.8d
Short % Float1.19%
Short % Out.1.19%
Shares Short4.42M
Short (prev mo.)4.77M
Technical
SMA 50476.41 (+10.6%)
SMA 200527.25 (-0.0%)
Beta0.87
S&P 52W Chg20.11%
Avg Vol (30d)1.55M
Avg Vol (10d)2.32M
Technical Indicators
RSI (14)65.0
MACD13.1155
MACD Signal10.3227
MACD Hist.+2.7927
BB Upper542.19 USD
BB Middle495.13 USD
BB Lower448.08 USD
BB Width19.01%
ATR (14)14.46 USD
Vol Ratio (20d)0.61x